[What follows is a brief report by BioQuick News Editor & Publisher Mike O’Neill on his experience virtually attending the live portion of the American Association for Cancer Research (AACR) 2020 Virtual Meeting II, with live sessions taking place July 22-24.] I just finished virtually attending much of the AACR Virtual Annual Mtg II (Mon-Wed, June 22-24). I even got in a few questions, including one on exosomes (see question at end of this note). The meeting had 37,000 registered attendees from 127 countries. Virtual attendees were rewarded with an incredible conference that included an opening day address by Nobel Prize winner Phillip Sharp and a closing day talk by a possible future Nobelist, NIH Director and former Genome Project leader Francis Collins. In his talk, Sharp mentioned that early in his career he had been recruited from Cold Spring Harbor Laboratory to MIT by Salvador Luria and David Baltimore. That put three future Nobelists in one lab. Not too bad. Collins described a number of COVID-19 efforts that are being undertaken currently by the NIH. His address from his NIH office was given in one of three COVID-19 sessions the AACR offered during this exceptional meeting. In his closing remarks, new AACR President Antoni Ribas noted that this fantastic meeting featured over 600 speakers, 125 sessions, 14 concurrent channels, and over 4,000 abstracts. All the meeting material will be available online to current and future registrants (registration is free) until September 23. Outgoing AACR President Elaine Mardis expressed her profound gratitude to everyone involved in the conference, including the major sponsor Daiichi-Sankyo, which had made it possible to offer the conference for free to registrants.
Login Or Register To Read Full Story